English | Español
Patient Daily | Apr 16, 2026

FDA’s transparency policy on rejection letters changes biopharma communication practices
Patient Daily | Apr 16, 2026

Revolution Medicines reports pancreatic cancer drug doubles survival in late-stage trial
Patient Daily | Apr 16, 2026

Allogene reports early success for cell therapy in lymphoma trial interim analysis
Patient Daily | Apr 16, 2026

BioNTech and DualityBio report mid-stage trial results for endometrial cancer treatment
Patient Daily | Apr 16, 2026

FDA shows flexibility in rare disease drug trials amid evolving regulations
Patient Daily | Apr 16, 2026

Mohawk SmartStrand carpet styles receive asthma and allergy friendly certification
Patient Daily | Apr 16, 2026

Study links treatable ear conditions to higher dementia risk, finds treatment may lower odds
Patient Daily | Apr 16, 2026

Researchers review super-enhancer mechanisms as potential targets for cancer therapy

Trending
+ Pharmaceuticals
Patient Daily | Jun 18, 2026

FDA seen as more flexible under acting commissioner Kyle Diamantas
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Pharmaceuticals
Patient Daily | Jun 16, 2026

Intellia gene editing therapy shows strong results in hereditary angioedema study
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

PwC reports strong biopharma M&A activity as sector shifts to precision science